Discontinued — last reported Q3 '14

Intangible Assets Gross (Excluding Goodwill)

Non-Current Assets

Amgen Intangible Assets Gross (Excluding Goodwill) decreased by 0.7% to $55.01B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.1%, from $56.19B to $55.01B. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2009
Last reportedQ3 2014

How to read this metric

An increase suggests significant investment in R&D or strategic acquisitions of intellectual property, which may drive future revenue growth.

Detailed definition

This represents the total acquisition cost of non-physical assets such as patents, trademarks, and licenses, excluding g...

Peer comparison

A key metric for pharma and tech companies to compare the depth of their patent portfolios and intellectual property moats.

Metric ID: intangible_assets_gross_excluding_goodwill

Historical Data

8 periods
 Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$56.45B$56.23B$56.22B$56.19B$56.12B$55.35B$55.41B$55.01B
QoQ Change-0.4%-0.0%-0.0%-0.1%-1.4%+0.1%-0.7%
YoY Change-0.6%-1.6%-1.4%-2.1%
Range$55.01B$56.45B
CAGR-1.5%
Avg YoY Growth-1.4%
Median YoY Growth-1.5%

Frequently Asked Questions

What is Amgen's intangible assets gross (excluding goodwill)?
Amgen (AMGN) reported intangible assets gross (excluding goodwill) of $55.01B in Q3 2025.
How has Amgen's intangible assets gross (excluding goodwill) changed year-over-year?
Amgen's intangible assets gross (excluding goodwill) decreased by 2.1% year-over-year, from $56.19B to $55.01B.
What does intangible assets gross (excluding goodwill) mean?
The total cost of intellectual property and other non-physical assets, excluding goodwill.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.